From the plant to the patient

 

On our plantations, the raw materials for our products are grown under controlled conditions, following the guidelines of Good Agricultural Practice (GAP). During the growing period, changes in the levels of active compounds are monitored in order to harvest at the best possible time.

Controlled biological management promotes the self-regulatory mechanisms between pest and beneficial species, so that the use of insecticides is minimised.
After the extraction process is complete, the plant residues are not dumped. They serve as natural organic fertilisers.

Our special extracts are prepared using modern pharmaceutical technology.
From the experience derived in pilot plants, scaling-up to the industrial extraction process is performed in-house.

The primary extracts go through further processing, which increases the concentration of active principles and reduces the quantity of non-desirable substances. The solvent, the type and number of purification and enrichment stages, and many other processing steps determine the exact composition of our special plant extracts. Finally, the plant extract is processed into different pharmaceutical forms such as tablets, capsules or liquid preparations.

All manufacturing stages, from raw plant material testing to final release of the product, are carried out on our group‘s own premises and are documented in accordance with the international requirements of the Good Manufacturing Practice (GMP) guidelines, issued by the World Health Organization (WHO).